Who invested in Aptadir Therapeutics?
Aptadir Therapeutics's investors include CDP Venture Capital, 4BIO Capital, Club degli Investitori, Angelini Ventures and Kerna Ventures, and 5 more on record. 4BIO Capital led its latest round.

United Kingdom · Seed startup
Funding summaryUpdated 26 Oct 2026
$47Mraised across 2 rounds since 2024, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Aptadir Therapeutics's investors include CDP Venture Capital, 4BIO Capital, Club degli Investitori, Angelini Ventures and Kerna Ventures, and 5 more on record. 4BIO Capital led its latest round.
Aptadir Therapeutics has raised $47M across 2 rounds since 2024.
Aptadir Therapeutics's most recent round was a Seed of $46M in Sept 2026, led by 4BIO Capital.
Its most recent round, $46M in Sept 2026, is also its largest on record.
Aptadir Therapeutics's first round on record, in Sept 2024, was backed by CDP Venture Capital.
Aptadir Therapeutics's latest named round is a Seed, in Sept 2026.
Aptadir Therapeutics is based in the United Kingdom.
4BIO Capital led the Seed in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.